摘要
目的探讨血清CA125和TPS水平联合检测在卵巢肿瘤诊断中的价值,为卵巢肿瘤的诊断与病情监测提供新方法。方法用ELISA法分别检测卵巢良性肿瘤和卵巢癌患者术前及化疗前血清CA125和TPS水平。结果卵巢癌患者血清CA125和TPS水平均较良性肿瘤患者高,差异有显著性(P<0.01)。血清CA125和TPS诊断卵巢癌的敏感度和特异度无差别。结论血清CA125和TPS水平可作为卵巢癌诊断与监测病情变化的临床指标。
Objective To investigate the clinical value of combined detection of the serum levels of CA125 and TPS in the diagnosis of ovary cancer and the observation of the curative effect.Methods Serum levers of CA125 and TPS in patients with benign ovary tumor and patients with ovary cancer were measured by ELISA.Results The levers of CA125 and TPS in the diagnosis of ovary cancer were signed evidently higher than those in benign ovary tumor （P〈0.01）.Serum CA125 and TPS showed similar sensitivities and specificities in diagnosis of ovary cancer.Conclusion Serum CA125 and TPS are both useful in the diagnosis and monitoring of ovarian cancer.
出处
《中国现代医药杂志》
2010年第3期67-68,共2页
Modern Medicine Journal of China
